ANTENGENE CORP. DL-,0001
0.420EURD
+0.004+0.96%
As of today at 06:02 GMT
EUR
No trades
Next report date
≈
August 22
Report period
H1 2025
EPS estimate
−0.03 EUR
Revenue estimate
7.93 M EUR
−0.066 EUR
−43.03 M EUR
12.39 M EUR
420.84 M
About ANTENGENE CORP LTD
Sector
Industry
CEO
Jian Ming Mei
Website
Headquarters
Suzhou
Founded
2018
FIGI
BBG010JWLT55
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company, which engages in oncology medicines, R&D capabilities, and differentiated strategic approach to developing novel oncology therapies. It operates in the segments of the pharmaceutical, biotechnology and other related markets that address oncology diseases. The company was founded by Jian Ming Mei on August 28, 2018, and is headquartered in Shanghai, China.
−490%
−430%
−370%
−310%
−250%
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−63.00 M
−42.00 M
−21.00 M
0.00
21.00 M
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−24.00 M
−16.00 M
−8.00 M
0.00
8.00 M
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−21.00 M
−14.00 M
−7.00 M
0.00
7.00 M
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−120.00 M
−60.00 M
0.00
60.00 M
120.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ANTENGENE CORP. DL-,0001 stocks are traded under the ticker 722.
We've gathered analysts' opinions on ANTENGENE CORP. DL-,0001 future price: according to them, 722 price has a max estimate of 0.78 EUR and a min estimate of 0.25 EUR. Watch 722 chart and read a more detailed ANTENGENE CORP. DL-,0001 stock forecast: see what analysts think of ANTENGENE CORP. DL-,0001 and suggest that you do with its stocks.
Yes, you can track ANTENGENE CORP. DL-,0001 financials in yearly and quarterly reports right on TradingView.
ANTENGENE CORP. DL-,0001 is going to release the next earnings report on Aug 22, 2025. Keep track of upcoming events with our Earnings Calendar.
722 earnings for the last half-year are −0.03 EUR per share, whereas the estimation was −0.04 EUR, resulting in a 7.41% surprise. The estimated earnings for the next half-year are −0.03 EUR per share. See more details about ANTENGENE CORP. DL-,0001 earnings.
ANTENGENE CORP. DL-,0001 revenue for the last half-year amounts to 4.12 M EUR, despite the estimated figure of 4.57 M EUR. In the next half-year revenue is expected to reach 7.93 M EUR.
722 net income for the last half-year is −20.53 M EUR, while the previous report showed −21.63 M EUR of net income which accounts for 5.13% change. Track more ANTENGENE CORP. DL-,0001 financial stats to get the full picture.
No, 722 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 22, 2025, the company has 169 employees. See our rating of the largest employees — is ANTENGENE CORP. DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANTENGENE CORP. DL-,0001 EBITDA is −45.53 M EUR, and current EBITDA margin is −367.42%. See more stats in ANTENGENE CORP. DL-,0001 financial statements.
Like other stocks, 722 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANTENGENE CORP. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.